These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19689861)

  • 41. Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.
    Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
    Clin Infect Dis; 2014 Feb; 58(4):517-25. PubMed ID: 24300040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.
    Chen CJ; Bakeera-Kitaka S; Mupere E; Kasirye P; Munube D; Idro R; Hume H; Pfeffer B; LaRussa P; Green NS
    J Paediatr Child Health; 2019 Jul; 55(7):795-801. PubMed ID: 30411430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.
    Leal J; Vanderkooi OG; Church DL; Macdonald J; Tyrrell GJ; Kellner JD
    Pediatr Infect Dis J; 2012 Sep; 31(9):e169-75. PubMed ID: 22673137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007.
    Bettinger JA; Scheifele DW; Kellner JD; Halperin SA; Vaudry W; Law B; Tyrrell G;
    Vaccine; 2010 Feb; 28(9):2130-6. PubMed ID: 20044050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
    Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine.
    Calbo E; Díaz A; Cañadell E; Fábrega J; Uriz S; Xercavins M; Morera MA; Cuchi E; Rodríguez-Carballeira M; Garau J;
    Clin Microbiol Infect; 2006 Sep; 12(9):867-72. PubMed ID: 16882291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.
    Myint TT; Madhava H; Balmer P; Christopoulou D; Attal S; Menegas D; Sprenger R; Bonnet E
    Adv Ther; 2013 Feb; 30(2):127-51. PubMed ID: 23397399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Invasive Pneumococcal Disease in Patients With Sickle Cell Disease.
    Navalkele P; Özgönenel B; McGrath E; Lephart P; Sarnaik S
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):341-344. PubMed ID: 28538501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
    Rosen JB; Thomas AR; Lexau CA; Reingold A; Hadler JL; Harrison LH; Bennett NM; Schaffner W; Farley MM; Beall BW; Moore MR;
    Clin Infect Dis; 2011 Jul; 53(2):137-43. PubMed ID: 21690620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epidemiology of invasive pneumococcal disease in children in Gipuzkoa (Spain) from 1981 to 2001].
    Iglesias Sánchez L; Pérez-Yarza EG; García-Arenzana JM; Valiente Méndez A; Pérez-Trallero E
    An Esp Pediatr; 2002 Nov; 57(5):401-7. PubMed ID: 12467542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012.
    von Mollendorf C; Cohen C; de Gouveia L; Naidoo N; Meiring S; Quan V; Lindani S; Moore DP; Reubenson G; Moshe M; Eley B; Hallbauer UM; Finlayson H; Madhi SA; Conklin L; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
    Pediatr Infect Dis J; 2015 Jan; 34(1):27-34. PubMed ID: 24992122
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
    Motlova J; Benes C; Kriz P
    Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
    Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
    Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Andersen PH; Howitz M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2010 Mar; 28(14):2642-7. PubMed ID: 20096392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.
    Shibl A; Memish Z; Pelton S
    Int J Antimicrob Agents; 2009 May; 33(5):410.e1-9. PubMed ID: 18976887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010.
    Thoon KC; Chong CY; Tee NW
    Int J Infect Dis; 2012 Mar; 16(3):e209-15. PubMed ID: 22281191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
    Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
    Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.